ArticlebioRxiv : the preprint server for biology2026
Spatiotemporal cell type deconvolution leveraging tissue structure.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Spot-based spatial transcriptomics (ST) captures aggregated transcriptomic profiles at spatial locations (spots) in tissue slices. Cell type deconvolution methods decode each spot and estimate the proportion of every cell type in the spot, necessary for uncovering spatial cell type distributions for further downstream analyses. Existing methods utilize cell type markers or reference transcriptomic (scRNA-seq) atlases at single cell (sc) resolution, or by aggregating profiles of identified cell types. However, current methods fail to effectively utilize the 3D tissue layout and single cell resolution reference. Some leverage 2D spatial organization assuming proximal spots are similar, which may be violated around boundaries or isolated cell types. We present SpaDecoder, a parallelized matrix factorization-based per-spot deconvolution method for multiple 3D spatial or temporal ST tissue slices effectively leveraging tissue structure with an adaptively inferred 3D neighborhood Gaussian kernel. We additionally account for variability in sc-reference profiles, along with batch effects. The mathematical framework of SpaDecoder allows it to be used for a range of downstream analyses. It can decode anteroposterior variability, impute gene expression, uncover putatively key tissue regions, identify colocalized cell types and predict spatio-temporal scRNA-seq cell locations. Ablation tests along with comparisons against other methods on various metrics, datasets, and scenarios, collectively show that SpaDecoder effectively harnesses 3D tissue structure and sc-reference profiles to improve cell type deconvolution. SpaDecoder is available at https://github.com/ZhangLabGT/spadecoder.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.